Eli Lilly (LLY) saw notable developments in September, with the launch of Lilly TuneLab, an AI/ML platform designed to ...

Eli Lilly plans to build a massive $5.9 billion campus that could change the landscape of Northeast Houston’s Generation Park ...

Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly’s “TuneLabs” platform, which the ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight.

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.